glp-1 receptor agonist and dpp-4 inhibitor combination not recommended The Role of Inhibitors in the Treatment Algorithm of Type 2 Diabetes Mellitus: When to Select, What to Expect DPP4 Inhibitors vs GLP-1 Agonists

This newly published case report describes pregnancy in lysinuric protein intolerance (LPI) complicated by established immune dysregulation, severe thrombocytopenia and episodes of hyperammonaemia, a combination not previously reported

doi: 10.1111/dom.13160

Abrupt discontinuation followed by immediate full-dose initiation of a new medication increases side effect risk and may cause a temporary rebound in appetite and weight

Glucagon-like refers to the fact that the structure of GLP-1 resembles that of glucagon, a hormone involved in regulating blood sugar

this study examined this relationship

These cells have a myriad of functions including sensing of the various nutrients we ingest (carbs, fats, amino acids) along with detection of pathogens and inflammatory signals